Literature DB >> 29139255

[Association rules analysis for exploring combined medication characteristics of Fufang Kushen injection: real-world study based on 49 597 cases].

Yin Zhang1, Yan-Ming Xie1, Yan-Nan Li2,3, Chang Zhang4, Cen Chen4, Yan Zhuang5.   

Abstract

The present study aimed to analyze the association rules of Fufang Kushen injection in combined medications in the real world based on electrical medical records in hospital information system, and provide reference for its reasonable clinical application. The electrical medical records of the hospitalized patients using Fufang Kushen injection were extracted to analyze the frequency distribution characteristics in combined application with Western medicine, and analyze the specific association rules between these combinations by using Apriori algorithm. A total of 49 597 patients were included in the study, and its common combined medications included 5-HT receptor blockers, hepatic protector, antibiotics, chemotherapeutic drugs, immunomodulatory drugs, glucocorticoids, analgetics and proton pump inhibitors. The results revealed that the distribution characteristics in combined application and association combinations of Fufang Kushen injection had specific rules, consistent with the clinical orientation of this drug in treatment of malignant tumor. Such results may provide reference for reasonable application of Fufang Kushen injection in clinical treatment. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  Fufang Kushen injection ; association rules ; hospital information system ; medication combination ; real world

Mesh:

Substances:

Year:  2017        PMID: 29139255     DOI: 10.19540/j.cnki.cjcmm.20170705.009

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.

Authors:  Zixin Shu; Yana Zhou; Kai Chang; Jifen Liu; Xiaojun Min; Qing Zhang; Jing Sun; Yajuan Xiong; Qunsheng Zou; Qiguang Zheng; Jinghui Ji; Josiah Poon; Baoyan Liu; Xuezhong Zhou; Xiaodong Li
Journal:  Front Med       Date:  2020-09-14       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.